BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 12203197)

  • 1. Pathogenesis of parathyroid dysfunction in end-stage renal disease.
    Silver J
    Adv Ren Replace Ther; 2002 Jul; 9(3):159-67. PubMed ID: 12203197
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cellular and molecular mechanisms of secondary hyperparathyroidism.
    Silver J; Levi R
    Clin Nephrol; 2005 Feb; 63(2):119-26. PubMed ID: 15730054
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regulation of PTH synthesis and secretion relevant to the management of secondary hyperparathyroidism in chronic kidney disease.
    Silver J; Levi R
    Kidney Int Suppl; 2005 Jun; (95):S8-12. PubMed ID: 15882315
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
    Brandi L
    Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The regulation of parathyroid hormone secretion and synthesis.
    Kumar R; Thompson JR
    J Am Soc Nephrol; 2011 Feb; 22(2):216-24. PubMed ID: 21164021
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High phosphate level directly stimulates parathyroid hormone secretion and synthesis by human parathyroid tissue in vitro.
    Almaden Y; Hernandez A; Torregrosa V; Canalejo A; Sabate L; Fernandez Cruz L; Campistol JM; Torres A; Rodriguez M
    J Am Soc Nephrol; 1998 Oct; 9(10):1845-52. PubMed ID: 9773785
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Calcium, phosphate, vitamin D, and the parathyroid.
    Marks KH; Kilav R; Naveh-Many T; Silver J
    Pediatr Nephrol; 1996 Jun; 10(3):364-7. PubMed ID: 8792407
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vitamin D retains an important role in the pathogenesis and management of secondary hyperparathyroidism in chronic renal failure.
    Cozzolino M; Gallieni M; Brancaccio D; Arcidiacono T; Bianchi G; Vezzoli G
    J Nephrol; 2006; 19(5):566-77. PubMed ID: 17136683
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The molecular basis of secondary hyperparathyroidism in chronic renal failure.
    Rahamimov R; Silver J
    Isr J Med Sci; 1994 Jan; 30(1):26-31. PubMed ID: 8138394
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pathogenesis of secondary hyperparathyroidism.
    Slatopolsky E; Brown A; Dusso A
    Kidney Int Suppl; 1999 Dec; 73():S14-9. PubMed ID: 10633458
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pathogenesis and medical treatment of secondary hyperparathyroidism.
    Fukagawa M; Kurokawa K
    Semin Surg Oncol; 1997; 13(2):73-7. PubMed ID: 9088062
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pathogenesis of secondary hyperparathyroidism.
    Slatopolsky E; Delmez JA
    Am J Kidney Dis; 1994 Feb; 23(2):229-36. PubMed ID: 8311080
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mechanisms of secondary hyperparathyroidism.
    Silver J; Kilav R; Naveh-Many T
    Am J Physiol Renal Physiol; 2002 Sep; 283(3):F367-76. PubMed ID: 12167586
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Renal osteodystrophy, phosphate homeostasis, and vascular calcification.
    Hruska KA; Saab G; Mathew S; Lund R
    Semin Dial; 2007; 20(4):309-15. PubMed ID: 17635820
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Medical management of secondary hyperparathyroidism in chronic renal failure.
    Goodman WG
    Nephrol Dial Transplant; 2003 Jun; 18 Suppl 3():iii2-8. PubMed ID: 12771290
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Secondary hyperparathyroidism in chronic renal failure.
    Wills MR; Savory J
    Ann Clin Lab Sci; 1981; 11(3):252-61. PubMed ID: 6264838
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regulation of parathyroid hormone synthesis in chronic renal failure in rats.
    Fukagawa M; Kaname S; Igarashi T; Ogata E; Kurokawa K
    Kidney Int; 1991 May; 39(5):874-81. PubMed ID: 2067203
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The calcimimetic AMG 073 as a potential treatment for secondary hyperparathyroidism of end-stage renal disease.
    Quarles LD; Sherrard DJ; Adler S; Rosansky SJ; McCary LC; Liu W; Turner SA; Bushinsky DA
    J Am Soc Nephrol; 2003 Mar; 14(3):575-83. PubMed ID: 12595492
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pathogenesis of parathyroid dysfunction in end-stage kidney disease.
    Levi R; Silver J
    Pediatr Nephrol; 2005 Mar; 20(3):342-5. PubMed ID: 15549412
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hyperparathyroidism in chronic renal failure.
    Papapoulos SE; Brownjohn AM; Junor BJ; Marsh FP; Goodwin FJ; Hately W; Lewin IG; Tomlinson S; Hendy GN; O'Riordan JL
    Clin Endocrinol (Oxf); 1977 Dec; 7 Suppl():59s-65s. PubMed ID: 606426
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.